LINDA ALLIBALOGUN: Open Payments
NPI 1255689717 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $1,026
Travel & lodging: $602Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $789 |
| ABBVIE INC. | 4 | $89 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Tris Pharma Inc | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, Auvelity, Dyanavel XR, TRINTELLIX, CAPLYTA.
Industry payments across MD — which companies pay providers there.
